Pancytopenia News and Research

RSS
UCB to sponsor several key sets of Cimzia data on RA at ACR 2011 meeting

UCB to sponsor several key sets of Cimzia data on RA at ACR 2011 meeting

UCB to present new data on Cimzia at ACG annual scientific meeting

UCB to present new data on Cimzia at ACG annual scientific meeting

New positive Cimzia phase IIIb study data on rheumatoid arthritis presented at EULAR meeting

New positive Cimzia phase IIIb study data on rheumatoid arthritis presented at EULAR meeting

Journal of Rheumatology publishes positive results from Cimzia Phase III trial in RA

Journal of Rheumatology publishes positive results from Cimzia Phase III trial in RA

Alexion Pharmaceuticals reports interim results from phase 1 trial on samalizumab antibody

Alexion Pharmaceuticals reports interim results from phase 1 trial on samalizumab antibody

Zyvox achieves higher clinical success rate than vancomycin in MRSA nosocomial pneumonia study

Zyvox achieves higher clinical success rate than vancomycin in MRSA nosocomial pneumonia study

UCB presents P3, P4 clinical trial data for Crohn's disease at ACG Scientific Meeting

UCB presents P3, P4 clinical trial data for Crohn's disease at ACG Scientific Meeting

ACG meeting to exhibit Cimzia data for Crohn's disease treatment

ACG meeting to exhibit Cimzia data for Crohn's disease treatment

Cimzia approved in U.S. for rheumatoid arthritis

Cimzia approved in U.S. for rheumatoid arthritis

European Commission and US FDA approve intravenous formulation of temozolomide

European Commission and US FDA approve intravenous formulation of temozolomide